Carola Ries
CR
Carola Ries
Chief Scientific Officer
Rate
About
Dr. Carola Ries is the Chief Scientific Officer at Macomics, an immuno-oncology company focused on macrophage-based drug discovery. She has over 20 years of experience in immunology and drug discovery, with a strong background in cancer immunotherapy. Prior to joining Macomics, she led Roche's innate immunity department in cancer immunotherapy and was involved in the discovery and clinical translation of emactuzumab (CSF1R program).
Frequently asked
Who is Carola Ries?
Dr. Carola Ries is the Chief Scientific Officer at Macomics, an immuno-oncology company focused on macrophage-based drug discovery. She has over 20 years of experience in immunology and drug discovery, with a strong background in cancer immunotherapy. Prior to joining Macomics, she led Roche's innate immunity department in cancer immunotherapy and was involved in the discovery and clinical transla…
What is Carola Ries's current role?
Carola Ries is currently Chief Scientific Officer.
Comments
No comments yet. Be the first to share your take.
Profile
About Carola Ries
Carola Ries is Chief Scientific Officer. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.